Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have rectal cancer and at least one swollen lymph node in the side of your pelvis that is either 7mm or larger, or between 5–7mm but shows one or more signs of concern (such as a round shape, uneven edges, mixed appearance, or loss of normal structure) on a scan.
Who may not be able to join:
- You are under 18 years old
- You have previously had radiation treatment to your pelvis
- You have previously had surgery to remove lymph nodes in the side of your pelvis due to a pelvic cancer
- Your cancer has already spread to other parts of the body at the same time as your rectal cancer diagnosis
- You have a condition called familial adenomatous polyposis (a hereditary bowel condition — confirm with trial site)
- You have colon cancer at the same time as your rectal cancer, and that colon cancer is at a more advanced stage than your rectal cancer
- You cannot safely receive a general anaesthetic for any reason
- You are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Miranda Kusters, MD, PhD, VUMedicalCentre
Phone: 0031204444444
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Lateral local recurrence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.